Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
8.7 USD | -6.05% | -16.10% | +41.69% |
Kurzporträt
Mitarbeiterzahl: 88
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Annie Ganot
FOU | Founder | - | 01.03.13 |
Ilan Ganot
FOU | Founder | 50 | 01.03.13 |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 29.09.22 |
Kevin Tan
DFI | Director of Finance/CFO | 46 | 09.01.23 |
Gabriel Brooks
CTO | Chief Tech/Sci/R&D Officer | - | 02.10.23 |
Jenny Marlowe
CTO | Chief Tech/Sci/R&D Officer | 47 | 01.01.23 |
Paul Herzich
CTO | Chief Tech/Sci/R&D Officer | 46 | 01.12.22 |
TY Howton
COO | Chief Operating Officer | 52 | 01.12.22 |
Shuli Kulak
PRN | Corporate Officer/Principal | - | - |
Jessie Hanrahan
LAW | General Counsel | 47 | 01.12.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Ian Smith
CHM | Chairman | 58 | 15.04.20 |
Martin Freed
BRD | Director/Board Member | 63 | 26.06.18 |
Raj Shah
BRD | Director/Board Member | 46 | 01.03.17 |
Adam Stone
BRD | Director/Board Member | 44 | 01.11.15 |
Director/Board Member | 58 | 12.09.18 | |
Alexander Cumbo
CEO | Chief Executive Officer | 53 | 29.09.22 |
Ilan Ganot
FOU | Founder | 50 | 01.03.13 |
Lynne Sullivan
BRD | Director/Board Member | 58 | 01.11.15 |
Georgia Keresty
BRD | Director/Board Member | 62 | 02.03.21 |
Clare Khan
BRD | Director/Board Member | 72 | 02.03.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 37 756 877 | 30 552 823 ( 80,92 %) | 0 | 80,92 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+41.69% | 350 Mio. | |
-3.10% | 102 Mrd. | |
+2.11% | 96.07 Mrd. | |
-1.80% | 21.66 Mrd. | |
-17.75% | 20.77 Mrd. | |
-6.91% | 18.53 Mrd. | |
-42.00% | 16.91 Mrd. | |
-28.19% | 13.79 Mrd. | |
+0.18% | 13.33 Mrd. | |
+19.90% | 10.94 Mrd. |
- Börse
- Aktien
- A3DXEC Aktie
- Unternehmen Solid Biosciences Inc.